Jump Financial, LLC

Position in XENE — Xenon Pharmaceuticals Inc.

CIK 1831577 Chicago, IL

Position in XENE

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$9,058,374

+$7,669,537 QoQ

Shares Held

155,776

+402.7% QoQ

Ownership

0.161%

of shares outstanding

% of Portfolio

0.18%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2021

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Jump Financial, LLC holds $252,735,812 across 133 Biotechnology names. XENE ranks #7 (3.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IONS	Ionis Pharmaceuticals Inc	206,675	$15,519,225
2	APLS	Apellis Pharmaceuticals, Inc.	291,488	$11,726,562
3	SRPT	Sarepta Therapeutics, Inc.	507,828	$11,050,335
4	DAWN	Day One Biopharmaceuticals, Inc.	497,365	$10,663,505
5	RARE	Ultragenyx Pharmaceutical Inc.	504,143	$10,561,795
6	LEGN	Legend Biotech Corp	516,633	$9,345,890
7	XENE	Xenon Pharmaceuticals Inc. This page	155,776	$9,058,374
8	BNTX	BioNTech SE	79,189	$7,038,317

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$9,058,374	155,776	+402.7%	Shares	Defined	2026-05-14
2025-12-31	$1,388,837	30,987	+376.7%	Shares	Defined	2026-02-17
2025-09-30	$260,975	6,500	-61.7%	Shares	Defined	2025-11-13
2025-06-30	$531,818	16,991	-62.2%	Shares	Defined	2025-08-13
2024-09-30	$1,771,650	45,000	-6.6%	Shares	Defined	2024-11-14
2024-06-30	$1,877,992	48,166	+4.5%	Shares	Defined	2024-11-14
2024-03-31	$1,983,700	46,079	+92.0%	Shares	Sole	2024-05-13
2023-12-31	$1,105,440	24,000	+210.7%	Shares	Sole	2024-02-07
2022-12-31	$304,596	7,725	-85.5%	Shares	Sole	2023-02-14
2022-09-30	$1,924,130	53,300	+77.1%	Shares	Sole	2022-11-07
2022-03-31	$920,187	30,101	-3.8%	Shares	Sole	2022-05-12
2021-12-31	$977,812	31,300	—	Shares	Sole	2022-02-10
No filing history on record for this holder in this stock.